🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "focused measures to tackle household expense pressures" in the upcoming Budget.

During an interview with media outlets, she noted that curbing inflation is a shared responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is projected to be the highest among the Group of Seven industrialized countries this calendar year and next.

Potential Energy Bill Measures

It is understood the government could take action to bring down energy bills, for example by cutting the current 5% rate of value-added tax applied on energy supplies.

An additional option is to cut some of the government charges currently added to household expenses.

Budgetary Limitations and Analyst Predictions

The administration will obtain the latest report from the official forecaster, the OBR, on Monday, which will clarify how much room there is for such measures.

The expectation from most analysts is that Reeves will have to announce tax rises or spending cuts in order to meet her voluntary fiscal targets.

Earlier on the same day, analysis suggested there was a £22 billion deficit for the Treasury chief to resolve, which is at the lower end of forecasts.

"It is a shared responsibility between the central bank and the administration to further reduce some of the sources of price increases," the Chancellor stated to the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and International Issues

While a great deal of the attention has been on likely tax increases, the Treasury chief said the most recent information from the OBR had not changed her vow to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She blamed an "unpredictable global environment" with increasing geopolitical and trade tensions for the fiscal tax moves, likely to be targeted on those "with the broadest shoulders."

International Trade Disputes

Addressing apprehensions about the United Kingdom's commercial links with China she said: "Our security interests invariably take priority."

Recent declaration by China to tighten trade restrictions on rare earths and other materials that are key for advanced tech production led US President Donald Trump to suggest an extra 100% tariff on goods from the Asian country, increasing the risk of an full-scale trade war between the two largest economies.

The American finance chief described the Chinese action "commercial pressure" and "a global supply chain control attempt."

Inquired about considering the US offer to participate in its battle with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "damaging for the international commerce and generates further challenges."

"In my view there are fields where we should challenge Chinese policies, but there are also significant chances to trade with Chinese markets, including financial services and other areas of the economy. We've got to maintain that balance appropriate."

The chancellor also confirmed she was working with G7 counterparts "regarding our own critical minerals plan, so that we are reduced dependence."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the cost the NHS spends on medicines could go up as a result of ongoing talks with the Trump administration and its drugs companies, in exchange for reduced taxes and funding.

A number of the world's largest drug companies have said in recent statements that they are either pausing or scrapping operations in the United Kingdom, with several blaming the low prices they are receiving.

Last month, the government science advisor said the price the NHS spends on drugs would must increase to prevent companies and drug research funding leaving the UK.

The Chancellor told media: "We have seen due to the pricing regime, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other EU nations."

"The objective is to ensure that individuals getting care from the National Health Service are able to receive the best life-saving treatments in the globe. And so we are reviewing this situation, and... aiming to obtain more investment into Britain."